Utama › Kanser (semua jenis) › Minnesota › Rochester
Kajian klinikal Kanser (semua jenis) di Rochester, MN
30 kajian untuk Kanser (semua jenis) sedang mencari peserta di lokasi dalam dan sekitar Rochester (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
Mengambil pesertaFasa 3
- Investigative Site, Rochester
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
Mengambil pesertaKajian pemerhatian
- Mayo Clinic Rochester, Rochester
A Study of JNJ-1761981 in Participants With Solid Tumors
Mengambil pesertaFasa 1
- Mayo Clinic Rochester, Rochester
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Mengambil pesertaFasa 2/3
- Mayo Clinic Cancer Center Outpatient Pharmacy, Rochester
- Mayo Clinic, Rochester
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
Mengambil pesertaFasa 3
- Mayo Clinic Hospital Rochester /ID# 279784, Rochester
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Mengambil pesertaFasa 2/3
- Mayo Clinic, Rochester
Statins to Prevent Cancer Associated Blood Clots
Mengambil pesertaFasa 4
- Mayo Clinic, Rochester
Biomarkers of Resiliency In Childhood Cancer Surgery
Mengambil pesertaKajian pemerhatian
- Mayo Clinic, Rochester
A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies
Mengambil pesertaFasa 1/2
- Mayo Clinic Rochester, Rochester
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
Mengambil pesertaKajian pemerhatian
- Mayo Clinic Rochester, Rochester
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Mengambil pesertaFasa 3
- Mayo Clinic-Comprehensive Cancer Center-Breast Clinic, Rochester
Project: Every Child for Younger Patients With Cancer
Mengambil pesertaKajian pemerhatian
- Mayo Clinic in Rochester, Rochester
Abatacept in Immune Checkpoint Inhibitor Myocarditis
Mengambil pesertaFasa 3
- Mayo Clinic, Rochester
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 1/2
- Mayo Clinic, Rochester
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Mengambil pesertaFasa 3
- Mayo Clinic in Rochester, Rochester
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
Mengambil pesertaFasa 1
- Mayo Clinic - Rochester /ID# 251164, Rochester
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
Mengambil pesertaFasa 2
- Mayo Clinic-Rochester /ID# 273508, Rochester
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
Mengambil pesertaFasa 1
- Mayo Clinic, Rochester
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
Mengambil pesertaFasa 1/2
- Mayo Clinic Rochester, Rochester
Patient Derived Preclinical Models
Mengambil pesertaKajian pemerhatian
- Mayo Clinic in Rochester, Rochester
The Sarah Nanotechnology System for Treatment of Advanced Metastatic Solid Tumors Using Hyperthermia.
Mengambil peserta
- Mayo Clinic, Rochester
A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors
Mengambil pesertaFasa 1
- Mayo Clinic Rochester, Rochester
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Mengambil pesertaFasa 2
- Mayo Clinic, Rochester
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
Mengambil pesertaFasa 1/2
- Mayo Clinic, Rochester
INTERogating Cancer for Etiology, Prevention and Therapy Navigation
Mengambil pesertaKajian pemerhatian
- Mayo Clinic in Rochester, Rochester
Multi-Cancer Detection Observational Cohort Study
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- Mayo Clinic in Rochester, Rochester
Suprachoroidal Administration in Subjects With Metastases to the Choroid
Mengambil pesertaFasa 2
- Mayo Clinic, Rochester
Primary Tumor Research and Outcomes Network
Mengambil pesertaKajian pemerhatian
- Mayo Clinic, Rochester
Testicular Tissue Cryopreservation in Children
Mengambil peserta
- Mayo Clinic in Rochester, Rochester
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Mengambil pesertaFasa 1/2
- Mayo Clinic, Rochester
Kajian Kanser (semua jenis) di bandar lain
- Houston, TX121 kajian
- New York City, NY110 kajian
- Boston, MA86 kajian
- Los Angeles, CA73 kajian
- Nashville, TN65 kajian
- Philadelphia, PA59 kajian
- Durham, NC58 kajian
- Washington, DC58 kajian
- Chicago, IL51 kajian
- Seattle, WA49 kajian
- Atlanta, GA49 kajian
- Arlington, VA48 kajian
Kajian lain di Rochester
- Kanser Payudara42 kajian
- Kanser Paru-paru Bukan Sel Kecil37 kajian
- Kanser Metastatik31 kajian
- Kanser Kolorektal29 kajian
- Kanser Ovari29 kajian
- Mieloma Pelbagai24 kajian
- Kanser Prostat22 kajian
- Kegagalan Jantung22 kajian
- Kanser Pankreas22 kajian
- Kanser Paru-paru20 kajian
- Kanser Endometrium20 kajian
- Leukemia Limfositik Kronik19 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.